Related Experiment Video
Updated: May 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Interventionalists beware: the apical thrombus!
Sinjini Biswas1, Andrew E Ajani
1Department of Cardiology, Royal Melbourne Hospital, Parkville, VIC 3050, Australia. sinjini.biswas@mh.org.au
Insights
Recent myocardial infarction (MI) increases stroke risk. Intravenous thrombolysis, a stroke treatment, was safely administered to a patient with recent MI, challenging contraindications.
Area of Science:
- Cardiology
- Neurology
- Stroke Medicine
Background:
- Recent myocardial infarction (MI) is a known risk factor for ischemic stroke.
- Patients experiencing stroke during the peri-infarct period are often hospitalized, facilitating access to early cerebral reperfusion therapies.
- However, recent MI is typically a contraindication for intravenous thrombolysis due to the risk of myocardial rupture.
Observation:
- This case report details the successful use of intravenous thrombolysis in a patient who had an acute myocardial infarct within 48 hours.
- The patient presented with acute ischemic stroke.
Findings:
- Intravenous thrombolysis was administered safely and effectively in a patient with acute ischemic stroke and recent myocardial infarction.
- This challenges the established contraindication for thrombolysis in this patient subgroup.
Implications:
- The findings suggest that intravenous thrombolysis may be a viable treatment option for acute ischemic stroke in select patients with recent MI.
- There is a need for evidence-based guidelines to manage stroke in patients with recent myocardial infarction.
- Further research is warranted to establish the safety and efficacy of thrombolysis in this high-risk population.
Abstract:
Recent myocardial infarction is a recognized risk factor for ischemic stroke. Patients who have a stroke in the peri-infarct period are usually in hospital and therefore well placed to access early cerebral reperfusion therapy. However, due to the risk of myocardial rupture, recent myocardial infarction is considered a contraindication to intravenous thrombolysis, which is usually the first-line therapy for the treatment of ischemic stroke. We report a case in which intravenous thrombolysis was safely and effectively used to treat acute ischemic stroke in a patient who had suffered an acute myocardial infarct within the previous 48 h. We also highlight the lack of evidence-based guidelines for the treatment of stroke in this important subgroup of patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

